(VIANEWS) – Shares of FibroGen (NASDAQ: FGEN) dropped 5.44% to $13.56 at 11:10 EST on Tuesday, after two consecutive sessions in a row of gains. NASDAQ is dropping 1.36% to $14,691.13, following the last session’s upward trend. This seems, up to now, an all-around down trend trading session today.
FibroGen’s last close was $14.34, 74.93% below its 52-week high of $57.21.
Today’s last reported volume for FibroGen is 209265 which is 81.46% below its average volume of 1128961.
FibroGen’s sales growth is 201.9% for the ongoing quarter and 13.3% for the next. The company’s growth estimates for the ongoing quarter is a negative 134.3% and positive 39.1% for the next.
Year-on-year quarterly revenue growth declined by 43.2%, now sitting on 171.82M for the twelve trailing months.
FibroGen’s last week, last month’s, and last quarter’s current intraday variation average was 0.54%, 0.83%, and 2.73%, respectively.
FibroGen’s highest amplitude of average volatility was 2.04% (last week), 2.58% (last month), and 2.73% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
FibroGen’s stock is considered to be oversold (<=20).
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $13.56 at 11:10 EST, way under its 52-week high of $57.21 and way higher than its 52-week low of $9.88.
FibroGen’s Moving Average
FibroGen’s value is way above its 50-day moving average of $11.90 and way below its 200-day moving average of $18.77.
More news about FibroGen (FGEN).